Why is oncologically depressed? How better to get out of depression?
Depression and malignant tumours occur, develop and fall into a vicious circle. Why is oncologically depressed?
1. Fear of disease When patients become aware that they have tumours, they often fall into fear of death. Their fear of deteriorating conditions, ineffective treatment, of the premature end of their lives and of being unable to accompany their families will be overshadowed by fear of uncertainty and death and become a breeding ground for depression.
2. Physical pain The tumor itself and the process of treatment (e.g. surgery, chemotherapy, treatment) can cause the patient great physical suffering. The pain of the surgical wounds, the vomiting of the chemotherapy, the withdrawal of the hair, the lack of strength and the skin damage caused by the treatment, among other things, have caused physical and psychological exhaustion. A prolonged period of physical suffering is prone to depression and depression.
3. Changes in the quality of life They may not be able to work properly and social activities are severely restricted. Pre-honored sports and hobbies have to be abandoned, and life can be reduced and dependent on others for care. This shift from being restricted to living on its own makes patients feel deprived of their value and dignity, and thus vulnerable to depression.
Oncological treatment is usually a long and expensive process, including various examinations, medications, hospitalization costs, etc. This is a heavy financial burden for many families. Patients see families giving birth to their own treatment, or fear that they will not be able to continue for financial reasons, creating a strong sense of guilt and anxiety, which further exacerbates depression.
5. The lack of social support may lead to people who feel alienated by friends and colleagues after a disease and to a shrinking social circle. Families, while concerned, may neglect emotional communication because of a lack of psychological understanding of the patient, or because they are too busy caring. Patients do not receive adequate psychological support and understanding, and feelings of loneliness and helplessness increase, leading to depression.
Many oncological patients generally begin to experience depression after a year, and this state is volatile and subject to adaptive change as the condition evolves and the external environment stresses. The risk of depression for cancer patients is significantly higher than for non-cancer-free populations. Depression can lead to a loss of faith in treatment and lack of cooperation, affecting the overall state of expression: display of mental illness, inactivity, appetite, panic and constipation. According to statistics, the mortality rate is higher among patients suffering from depression, as depression can exacerbate the adverse effects of treatment on tumours, affect the effects of treatment and even promote the recurrence, transfer, etc.
How does a tumor get out of depression?
Cancer patients can begin with depression, cognitive disorders, fatigue and sleep disorders, which can alleviate the problem to some extent.
1. Psycho-educative interventions. By communicating with patients, gradually changing the cognitive and mental patterns of patients on tumours, encouraging exercise and healthy recreation, developing personal interests, diverting attention and reducing psychosocial stress. Common elements include: the vulnerability of oncology patients to carcinogenic fatigue and the provision of expected guidance to patients with weak models; individualized referral of optimal levels of exercise and sleep/s rest patterns; guidance for motivation, self-care and active response; and recognition and encouragement for self-efficiency and increased control.
2. Actively face the disease Knowledge of oncology: Patients can learn more about the type of tumour they suffer, treatment methods and prognosis by communicating with doctors, reading authoritative medical information, etc. Knowledge is power, and fear and uncertainty diminish when there is a clearer understanding of disease. For example, some early tumours are treated with a high cure rate, and understanding of this can give hope to patients. Participation in treatment decision-making: Active communication with the medical team and participation in the development of treatment programmes. This gives the patient a sense of control over his or her condition, rather than being completely passive.
Easier training The study suggests that relaxation of training can significantly improve the carcinogenic fatigue and sleep problems of early breast cancer patients and breast cancer patients receiving complementary chemotherapy.
Antidepressants: For example, the re-ingestion inhibitor of 5-Oxamine can significantly reduce depression in breast cancer and can also improve cancer fatigue, as well as depression in post-chemical real cancer patients, but this is not effective for such patients. 5-Oxyxamine re-ingestion of inhibitor turrin is effective for anxiety, depression and inactivity of late-stage cancer patients. Atypical antidepressants of amphetamines can also improve depression and carcinogenic fatigue at the same time, and have good tolerance.
Summary
According to studies, anxiety is a risk factor for cancer, but it is a protective factor for certain cancers, such as colon cancer. Those who found out that they had characteristics of concern were often more frequently subjected to beta colonoscopy or colonoscopy-related examinations. It is therefore a reminder to populations of concern who are more inclined to seek medical assistance, which may lead to early detection of pre-cancer pathologies. So there’s no emotion that’s wrong. What we have to do is to keep our emotions stable and have a moderate control of their emotional state in order to be healthy and healthy!
Depression, cancer fear, cancer.
